Announcements and amendments to testing

Resumption of Orexin/Hypocretin level testing service

Our Orexin level testing service is now operational. If you have stored CSF samples for Orexin level testing, please send them as soon as possible.

Please contact us if you have any queries.

Announcements

• Increased turnaround times (pdf, 131 KB)
• User Feedback Survey Results 2021 (pdf, 176 KB)
• User Feedback Survey Results 2020 (pdf, 667 KB)
• Change in the Myositis Immunoblot repertoire (pdf, 388 KB)
• Myasthenia Gravis testing update (pdf, 409 KB)
• Change of technique for the measurement of paraneoplastic antigens by Immunoblot (pdf, 314 KB)
• Changes to testing platforms at Oxford Immunology for Neuroimmunology assays (pdf, 284 KB)
• Pre-payment of testing for international and individual users (pdf, 202 KB)

Allergy and ANCA testing

• Allergy testing
• ANCA testing policy

Amendments to testing

• Change to testing strategy, VGKC antibodies (pdf)
• Change to UK Screening Strategy for NMOSD (pdf)
  
• Change to Non-UK Screening Strategy for NMOSD (pdf)
  • Multi comparison paper for AQ4 (pdf)
• Introduction of an Equivocal Zone for the Voltage Gated Potassium Channel Assay Results (pdf)